Skip to main content

COVID-19 Vaccine

UPDATE as of 1/16/21:

We are not accepting NEW requests at this time. Additionally:

  • First dose appointments scheduled from Sunday, 1/17/21 through Sunday, 2/7/21, have been postponed. If you had an appointment, you will receive an email from us with further instructions on how to reschedule.
  • This is so that we can make sure everyone can receive their second dose, as scheduled.
  • If you have a SECOND DOSE appointment:
    • If your SECOND DOSE appointment is scheduled on a weekday (Mon-Fri) there are NO CHANGES.
    • If you had a SECOND DOSE appointment on Sunday, 1/17, Saturday, 1/23, Sunday 1/24, Saturday 1/30, Sunday 1/31, Saturday 2/6, or Sunday 2/7, you will receive an email with new days you can get your second dose.
    • Starting Monday, 1/18/21, the vaccine clinic is open Monday-Friday, 7:30 am - 8 pm for SECOND DOSE appointments ONLY.
    • Clinic is CLOSED on Sunday, January 17 and Monday, January 25

Unfortunately, we were just informed by the state that we will not be receiving the shipment we anticipated this week. Additionally, our next scheduled shipment will also contain less doses than we have requested. Because of this, we have made the difficult decision to postpone all first dose appointments to ensure that we have enough doses of the vaccine to provide second doses to those who will require them over the next few weeks.

We will continue to communicate updates as soon as possible. Mahalo for your patience. Please know that we are working tirelessly to advocate for more vaccines for our Maui community and we will not stop until every single person that wants to, is vaccinated.

If you already submitted a request form, we will respond to your requests as soon as possible. Please be patient.

If you got your first dose at UH Clinic (Moderna Vaccine) and need to contact someone about your second dose, please contact the Maui District Health Office UH Vaccine clinic to schedule that appointment at You CANNOT get your second dose at the hospital (Pfizer Vaccine).

If you already submitted a request form, please review the important notes below AND the VAMS JOB AID for assistance.


  • Please DO NOT walk in. We understand everyone is anxious to get their vaccine but in order to keep it a safe and efficient process, we ask you to follow directions and make an appointment. Unless you have been provided a SECOND DOSE WALK-IN TIME, you WILL NOT be provided a vaccine.

  • DO NOT use the same email for more than one person. The VAMS system identifies the user by their email and each email address can only be connected to ONE PERSON.

  • Please only submit the appointment request form ONCE. Submitting multiple forms per person will delay your account being set up.
  • You MUST select Maui Health – MMMC Main Lobby location. If you select any other location, you will be turned away when you arrive for your appointment.
  • Please BE PATIENT. Due to an overwhelming number of requests, it may take longer to receive your VAMS email or any email communication from our team. We are working as fast as we can and we appreciate your patience. We can assure you that we will be able to serve anyone and everyone who qualifies, but it may take some time. Thank you for your understanding and support!

  • If you think you made an error on your appointment request form, please email DO NOT RESUBMIT the form.

  • Please take the time to review the instructions BEFORE you proceed with the appointment request form and the VAMS registration.

MAHALO for following these important steps and helping us expedite all the requests!


Is Maui Health offering vaccinations to the general public?

UPDATE - January 16, 2021

We are not accepting NEW requests at this time.

Unfortunately, we were just informed by the state that we will not be receiving the shipment we anticipated this week. Additionally, our next scheduled shipment will also contain less doses than we have requested. Because of this, we have made the difficult decision to postpone all first dose appointments to ensure that we have enough doses of the vaccine to provide second doses to those who will require them over the next few weeks.

We will continue to communicate updates as soon as possible. Mahalo for your patience. Please know that we are working tirelessly to advocate for more vaccines for our Maui community and we will not stop until every single person that wants to, is vaccinated.

Starting Friday, January 8, 2021, Maui Health will provide vaccinations to community members who are included in the Centers for Disease Control (CDC) identified Phase 1A and Phase 1B vaccine prioritization timeline. This includes Hawaii residents who are:

  1. Healthcare Workers
  2. Frontline Essential Workers (click for details)
  3. Adults ages 75+

If you qualify and would like to receive the vaccine at Maui Health, please stand by until we open up the appointment request form again.

I’m 65 and older, can I come to the hospital to get my vaccine? If not, when do I qualify to receive a vaccine and will Maui Health offer to the general public who are 65 or older?

  • See question #1 above.
  • Hawaii residents ages 65 and older are included in Phase 1C. At this time, a start date has not been determined yet.
  • If you are interested in receiving the vaccine as soon as it is available to your group, we recommend you follow the updates from the Hawaii State Department of Health at which includes a copy of Hawaii's draft COVID-19 Vaccination Plan.

Where will Maui County residents be able to get the vaccine and when?

See Question #1 above. If you are part of Phase 1A or 1B, you may qualify to get your vaccine at Maui Health.

Maui County will receive vaccines according to Hawaii’s COVID-19 Vaccination Plan. Each person’s eligibility to receive the vaccine is based on their level of risk of exposure. Those with the highest risk of exposure, like health care workers with direct patient care and first responders, are in the first phase or stage of distribution (stage 1a), followed by those with underlying health conditions as well as those aged 75+ in certain living conditions (stage 1b). According to the plan, Stage 3 and 4 opens up the vaccine to the general population that do not qualify via other risk factors like where they work, live, or any underlying medical conditions. At this time, early estimates indicate that the general population will be able to receive their vaccine sometime in the second quarter of 2021. Again, these are just estimates. To keep up to date with the latest Hawaii COVID-19 Vaccine updates, visit

Which manufacturer of the COVID-19 vaccine will Maui Health receive?

Maui Health received the Pfizer-BioNTech COVID-19 Vaccine which has been authorized for EUA by the FDA. Some of our long-term care facilities will likely receive the Moderna vaccine. It’s important to note you must receive the same vaccine for both doses from the same manufacturer.

Why are health care workers part of Phase I distribution?

  • Because initial vaccine supplies are limited, recommendations are being made for at-risk groups first. On December 2, 2020, the CDC made official recommendations, based on the recommendations from the Advisory Committee on Immunization Practices (ACIP) that health care workers are among the first to get the vaccine because of the increased risk of COVID-19 exposure and illness.

How will it be determined who gets the vaccine first among health care workers?

  • CDC is recommending that health care workers with direct patient care be vaccinated first. The Maui Health vaccination workgroup developed an internal allocation plan to determine cadence of vaccine distribution based off the CDC recommendations.

Is the vaccine mandatory for your staff to take?

  • It is not mandatory for staff to take the vaccine, just as it is not mandatory to receive the flu vaccine; however, it is HIGHLY recommended as the vaccine is over 94% effective in preventing a COVID-19 infection and a powerful defense in stopping the spread of the virus to our more vulnerable population.


(For the most recent updates on the COVID-19 vaccines, please visit

How was the COVID-19 vaccine developed and tested?

  • Approval of a vaccine for use in people involves multiple phases with different goals for assessing effectiveness and safety in different populations. There are four distinct phases, and the vaccine must meet very intense safety criteria before completing each phase. Once a vaccine is approved for use after phase 3, it has been tested in tens of thousands of people and if no significant harmful side effects are noted, it is considered safe for use. Phase 4 involves continued monitoring and gathering of safety data. This type of clinical trial has been used for decades to approve medications and vaccines.

What are the Food and Drug Administration (FDA) requirements for the safety and efficacy of a COVID-19 vaccine?

  • FDA requires 50% efficacy of a COVID-19 vaccine (the COVID-19 vaccines from Pfizer and Moderna are showing 94-95% efficacy in preventing COVID-19 disease during this trial phase). Many other companies are working on a vaccine and we expect that others will be approved by the FDA.
  • FDA requires 8 weeks (about 2 months) of safety data on the COVID-19 vaccine

What is an Emergency Use Authorization (EUA) and if the vaccine is approved for an EUA, what does that mean?

  • An EUA is based on the need to use a vaccine quickly to save lives during an urgent health crisis.
  • You may be anxious about the speed with which a vaccine has been approved. While the EUA is a shorter process, no steps are skipped in the safety evaluation process.
  • This approval can still take weeks and the U.S. Food and Drug Administration (FDA) will re-evaluate the numbers and data to ensure that the calculations are correct.
  • The FDA has reviewed and evaluated the vaccine’s risks and benefits as they would with all vaccines.
  • The FDA formally granted emergency approval for Pfizer-BioNTech’s coronavirus vaccine candidate on Friday, December 11, 2020.

How will we know it is safe?

  • Safety is the most important requirement for the vaccine and is assessed in trials by independent experts.
  • FDA advises a minimum of 3,000 participants to assess safety. The current phase 3 trials have 30,000 to 50,000 participants. Pfizer vaccine had 44,000 people participate in their clinical trials.

Who else will be evaluating this vaccine to ensure it is safe and effective?

  • There are two advisory committees: (1) The Vaccine and Related Biological Products Advisory Committee (VRBPAC) that advises the FDA 2020 Meeting Materials, Vaccines and Related Biological Products Advisory Committee | FDA; (2) The Advisory Committee on Immunization Practices (ACIP) that advises the CDC Advisory Committee on Immunization Practices (ACIP) | CDC
  • These advisory boards are independent from the FDA. Their job is to monitor vaccines to ensure safety regardless of money, politics, etc.
  • The people on these committees are experts from academic institutions and they are vetted to avoid a conflict of interest. Experts who may have a conflict of interest are not put on these committees.
  • The committees have evaluated the vaccine data for safety and efficacy and help to determine how it will be distributed.

What are the types of potential vaccines that may be approved?

  • The two vaccines we may receive are Messenger RNA (mRNA) vaccines (see question #7 below for more information). None of these can give you COVID-19! The goal is to give your body the tools it needs to fight COVID-19 effectively and/or prevent you from getting it at all.
  • None of the proposed vaccines contain live or killed viral particles, (see question #7 below for more information on how these new vaccines work).
  • Most of the vaccines that are currently being tested will require 2 doses to be effective, given about 3-4 weeks apart.
  • This is to make sure your body has enough antibodies to fight COVID-19. Getting 2 doses within 3-4 weeks has been shown to be safe and there are other vaccines we have been using for years that require multiple doses similarly without causing harm.

How does an mRNA vaccine work?

  • The vaccine is administered into our arm muscle (intramuscular injection) which gives our cells a message by using what is called a “spike protein.” This protein cannot build a virus or cause infection, it gives our cells instructions on how to make a harmless protein that is unique to the virus. After our cells make copies of the protein, they break it down and get rid of it. Our bodies recognize that the protein should not be there, and it builds antibodies that will remember how to fight the virus that causes COVID-19 if we are infected in the future.
  • While mRNA technology is new in vaccine development, this technology is being successfully used in cancer treatments.
  • For more information, visit the CDC website:

How much will the vaccine cost?

  • Currently, vaccine doses have been purchased by the federal government for immediate use and will be given to the American people at no cost. There may be an administrative cost for issuing the vaccine by Walgreens.

How long will the vaccine protect us?

  • This question will not be answered until more information and data is collected. Many have suspected it will be like the flu vaccine and will need to be given on a more regular basis.

How does the vaccine help with the spread of COVID-19?

  • Getting vaccinated is one of many steps you can take to protect yourself and others from COVID-19. Protection from COVID-19 is critically important because for some people, it can cause severe illness or death.
  • Stopping a pandemic requires using all the tools available. Vaccines work with your immune system so your body will be ready to fight the virus if you are exposed. Other steps, like masks and physical distancing, help reduce your chance of being exposed to the virus or spreading it to others. Together, COVID-19 vaccination and following the CDC’s recommendations to protect yourself and otherswill offer the best protection from COVID-19.

When will we be protected after we get the vaccine?

  • Most COVID-19 vaccines will require 2 shots, within 21-28 days (about 4 weeks) between each shot, and protection will usually occur about 2 weeks after the second shot.
  • Protection is not immediate and current practices such as wearing a mask, physical distancing and practicing frequent hand hygiene will need to be continued.
  • While no vaccine is 100% effective, the vaccines that have received EUA from the FDA are more than 94% effective. This will reduce the risk of getting sick with COVID-19.

After I have had the second dose of the vaccine and it is 2 weeks after my second shot, do I still have to wear a mask?

  • Yes, even though you have received your vaccine, most of the people around you have not. We know the vaccine prevents disease in the vaccinated person, but it still may be possible to transmit the disease to others, until the vaccine is in widespread use.
  • Wearing a mask, physical distancing, and practicing hand hygiene protects those who have not been vaccinated, especially our high-risk patients and residents in long-term care.

What if I had COVID-19 or took a test that showed I have antibodies? Should I get the vaccine?

  • Yes, even if you have had COVID-19, it is safe to get the vaccine and recommended.
  • If you have had a test that shows you have COVID-19 antibodies, you should still get the vaccine. It is safe and can increase your protection.

What are some of the possible side effects of the COVID-19 vaccine? Will the vaccine make me sick?

  • The vaccines currently being tested in clinical trials can cause short-term discomfort (such as headache, muscle pains, fatigue, chills, fever, and pain at injection site) in a small percentage of the people who receive them. This is the effect of your body developing immunity. Clinical trial participants reported that the discomfort went away after a day, sometimes sooner. When you receive the second dose of the vaccine, the discomfort can be more pronounced. This is a normal reaction.
  • If you experience discomfort after the first dose of the vaccine, it is especially important that you still receive the second dose a few weeks later for the vaccine to be effective.
  • This does not mean that the vaccine has given you COVID-19. Rather, this means that the vaccine is causing your body’s immune system to react and create antibodies to fight off the virus. In other words, if you feel some discomfort, then the vaccine is doing its job!
  • In some cases, a person may already be infected with COVID-19 when they get the vaccine but are asymptomatic or pre-symptomatic. If they later have symptoms of COVID-19 or test positive for it, it does not mean they got COVID-19 from the vaccine.

If I have symptoms of COVID-19 after receiving the vaccine, should I call out sick?

  • It will be important to understand the difference between side effects and symptoms consistent with COVID-19.
  • Common side effects include:
  • Pain or tenderness at the injection site, fatigue, headache, general aches.
  • These may last a few days.
  • We recommend taking the vaccine when you are scheduled to be off the next day, please plan accordingly.
  • Symptoms consistent with a COVID-19 Infection Include:
  • Fever, chills, cough, shortness of breath, fatigue/tiredness, muscle pain, sore throat, headache, runny nose, diarrhea, nausea/vomiting, loss of sense of taste, loss of sense of smell
  • If you develop a high fever or you develop symptoms consistent with COVID-19 that seem to get worse or if you have concerns, please call out sick. You also have the option to see the Employee Health APP.

What if I’m pregnant or plan to become pregnant, is the vaccine safe?

  • At this time, the safety of the vaccine has not yet been tested in pregnant women as the clinical studies conducted thus far did not include pregnant women.
  • If you are pregnant or planning to become pregnant, please discuss risks and benefits as well as questions or concerns with your OBGYN prior to deciding whether to get the vaccine.

What if I’ve had allergies to certain foods, medications, or other vaccines – is the vaccine safe?

  • You should not get the second dose of the Pfizer-BioNtech COVID-19 Vaccine if you had a severe allergic reaction after your first dose of this vaccine, or had a severe allergic reaction to any ingredient of this vaccine. If you have severe allergic reactions to certain foods or medications, please consult with your Primary Care Provider to determine if this vaccine is recommended for you. For additional information about the Pfizer-BioNTech vaccine, click here or visit

What are the ingredients in the Pfizer-BioNtech COVID-19 Vaccine?

  • The Pfizer-BioNTech COVID-19 Vaccine includes the following ingredients: mRNA, lipids ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate), 2 [(polyethylene glycol)-2000]-N,N-ditetradecylacetamide, 1,2-Distearoyl-sn-glycero-3- phosphocholine, and cholesterol), potassium chloride, monobasic potassium phosphate, sodium chloride, dibasic sodium phosphate dihydrate, and sucrose. For additional information about the Pfizer-BioNTech vaccine, click here or visit

Where can I find more information about the vaccine?